Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 14, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2020. Go to the latest filing (Q3 2026)

6.7B USDQ1 2020
Total value of stock positions
6.7B USD
Positions
32
Share of the ten largest
71.3%

The ten largest positions Q1 2020

  1. eBay Inc. 14.3%▲ +60.5%
  2. Liberty Global PLC 12.5%▲ +2.5%
  3. Fox Corporation (Class A) 9.6%unchanged
  4. Viasat Inc 7.3%unchanged
  5. Alphabet Inc. (Class C) 5.2%new
  6. HP Inc. 5.1%▲ +100.0%
  7. Meta Platforms 4.9%new
  8. Viacomcbs Inc 4.7%▲ +32.4%
  9. Cheniere Energy Inc 4.0%▼ −19.9%
  10. Qorvo Inc 3.7%▲ +11.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2020

Positions Q1 2020 per 13F filing, 5 of 5
Symbol Weight Shares Reported value Change Held since
Cheniere Energy Inc 4.0% 8,124,235 272.2M USD −19.9% reduced Q1 2014 25 quarters
COR Cencora 1.2% 936,299 82.9M USD −19.7% reduced Q3 2017 11 quarters
PCG PG&E Corporation 1.3% 9,702,443 87.2M USD −48.6% reduced Q1 2018 9 quarters
Univar Solutions Inc 0.9% 5,500,000 59.0M USD −42.1% reduced Q3 2018 7 quarters
Akebia Therapeutics Inc 2.0% 17,527,968 132.9M USD −10.4% reduced Q4 2018 6 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 28.7M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 28.7M USD

Breakdown by sector

  • Communication Services 21.6%
  • Consumer Discretionary 14.3%
  • Technology 5.1%
  • Health Care 4.6%
  • Utilities 1.3%
  • not in our coverage 53.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close